Fatty acid binding profile of the liver X receptor α

LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes

(2015) Megan V. Cannon et al.   DIABETOLOGIA

Ligand-Regulated Heterodimerization of Peroxisome Proliferator-Activated Receptor α with Liver X Receptor α

(2014) Madhumitha Balanarasimha et al.   BIOCHEMISTRY

A single amino acid change humanizes long-chain fatty acid binding and activation of mouse peroxisome proliferator-activated receptor α

(2014) Dhawal P. Oswal et al.   JOURNAL OF MOLECULAR GRAPHICS & MODELLING

Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors

(2013) Rajashri Sridharan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Divergence between human and murine peroxisome proliferator-activated receptor alpha ligand specificities

(2013) Dhawal P. Oswal et al.   JOURNAL OF LIPID RESEARCH

General Molecular Biology and Architecture of Nuclear Receptors

(2012) Michal Pawlak et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice

(2012) Yuan Zhang et al.   JOURNAL OF CLINICAL INVESTIGATION

Mechanisms of Gene Regulation by Fatty Acids

(2012) Anastasia Georgiadi et al.   Advances in Nutrition

Human SREBP1c Expression in Liver Is Directly Regulated by Peroxisome Proliferator-activated Receptor α (PPARα)

(2011) Ana Fernández-Alvarez et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Nuclear receptors as drug targets for metabolic disease

(2010) Ira G. Schulman   ADVANCED DRUG DELIVERY REVIEWS

Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C

(2010) Elena Lima-Cabello et al.   CLINICAL SCIENCE

Regulation of hepatic gene expression by saturated fatty acids

(2010) T. Vallim et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease

(2008) Nobito Higuchi et al.   HEPATOLOGY RESEARCH